文献速递血液净化与透析

加巴喷丁与普瑞巴林在血透患者中与不良结局的关联

Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients.
PubMed 文献 · J Am Soc Nephrol · 2018-06-05

本研究基于美国肾脏数据系统,纳入2011年140,899名接受血透的Medicare覆盖成人,采用Cox回归分析加巴喷丁和普瑞巴林与急诊或住院时意识改变、跌倒、骨折的关联。结果显示两种药物均与意识改变和跌倒风险升高相关,高剂量时风险更高,提示血透患者应谨慎使用。

要点

  • 加巴喷丁最高剂量组与意识改变、跌倒、骨折风险分别升高50%、55%、38%相关。
  • 即使较低剂量加巴喷丁也与意识改变(31%-41%)和跌倒(26%-30%)风险升高相关。
  • 普瑞巴林与意识改变和跌倒风险分别升高达51%和68%相关。

核心结论

  • 加巴喷丁和普瑞巴林在血透患者中应谨慎使用,需研究确定最佳剂量。

研究设计与样本

  • 回顾性队列研究,基于美国肾脏数据系统,纳入2011年140,899名接受血透的Medicare覆盖成人。
  • 使用Cox回归模型,调整人口学、合并症、暴露时长、药物数量及潜在混杂药物。

主要发现

  • 2011年,19%和4%的患者分别接受加巴喷丁和普瑞巴林。
  • 68%的加巴喷丁或普瑞巴林使用者有神经病理性疼痛、瘙痒或不宁腿综合征诊断。
  • 加巴喷丁最高剂量组(>300 mg)与意识改变、跌倒、骨折风险分别升高50%、55%、38%相关。
  • 加巴喷丁较低剂量也与意识改变(31%-41%)和跌倒(26%-30%)风险升高相关。
  • 普瑞巴林与意识改变和跌倒风险分别升高达51%和68%相关。

临床怎么用

  • 血透患者使用加巴喷丁或普瑞巴林时需评估风险,尤其注意意识改变和跌倒。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Gabapentin and pregabalin are used to manage neuropathic pain, pruritus, and restless legs syndrome in patients on hemodialysis. These patients may be especially predisposed to complications related to these agents, which are renally cleared, but data regarding the risk thereof are lacking.Methods From the US Renal Data System, we identified 140,899 Medicare-covered adults receiving hemodialysis with Part D coverage in 2011. Using Cox regression models in which we adjusted for demographics, comorbidities, duration of exposure, number of medications, and use of potentially confounding concomitant medications, we investigated the association between gabapentin and pregabalin, modeled as separate time-varying exposures, and time to first emergency room visit or hospitalization for altered mental status, fall, and fracture. We evaluated risk according to daily dose categories: gabapentin (>0-100, >100-200, >200-300, and >300 mg) and pregabalin (>0-100 and >100 mg).Results In 2011, 19% and 4% of patients received gabapentin and pregabalin, respectively. Sixty-eight percent of gabapentin or pregabalin users had a diagnosis of neuropathic pain, pruritus, or restless legs syndrome. Gabapentin was associated with 50%, 55%, and 38% higher hazards of altered mental status, fall, and fracture, respectively, in the highest dose category, but even lower dosing was associated with a higher hazard of altered mental status (31%-41%) and fall (26%-30%). Pregabalin was associated with up to 51% and 68% higher hazards of altered mental status and fall, respectively.Conclusions Gabapentin and pregabalin should be used judiciously in patients on hemodialysis, and research to identify the most optimal dosing is warranted.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ishida JH, McCulloch CE, Steinman MA, et al. Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients. J Am Soc Nephrol. 2018. PMID: 29871945. doi:10.1681/ASN.2018010096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。